Basket | Login


WS2. ALCOVE: Sharing knowledge to enlighten healthcare policies in Europe

Detailed Programme, abstracts and presentations

WS2. ALCOVE: Sharing knowledge to enlighten healthcare policies in Europe for People Living with Dementia and their Carers. An interactive workshop and consultation for people living with dementia, their families and supporters and those who work alongside them  (Friday, 5 October, 17.30-18.30, Europa 2)

Dawn Brooker, Simon Evans, Peter Ashley, Jenny La Fontaineand Jennifer Bray

Contributing Authors:

  • Dr Armelle Leperre – Desplanques,  Haute Autorité de Santé, France;
  • Tomás López-Peña Ordoñez, Institudo de Salud Carlos III, Spain;
  • Pr Michal Novak, Slovenska Akademia Vied – Neuroimmunologicky Ustav, Slovakia;
  • Pr Nicola Vanacore, Istituto Superiore di Sanita, Italy;
  • Dr Karim Saad, Regional Clinical Lead for Dementia, Coventry UK;
  • Pr Dawn Brooker; Dr Simon Evans, Jenny La Fontaine, University of Worcester, UK; Jerry Bird Department of Health, UK;
  • Dr Helka Hosia-Randel,  National Institute of Health and Welfare, Finland;
  • Bénédicte Gombault, King Baudoin Fundation, Belgium;
  • Pr Anders Wimo, Karolinska Institute, Sweden;

The ALzheimer’s COoperative Valuation in Europe (ALCOVE) project is a Joint Action co-financed by the European Commission and comprised of 30 partners from 19 EU Member States. ALCOVE aims to improve knowledge and promote the exchange of information on dementia and its consequences to preserve health, quality of life, autonomy, and dignity of people living with dementia and their carers in EU Member States. ALCOVE’s main objectives are: 1) To establish a European network of healthcare institutions; 2) to inform and advise policymakers, healthcare professionals, caregivers, and citizens through convergent recommendations; 3) to reduce the risks associated with psychotropic drug use, particularly antipsychotics.

ALCOVE aims to improve data on dementia prevalence; access to early dementia diagnosis; care for those living with dementia, especially those with behavioural and psychological symptoms; and the rights of people with dementia, particularly with respect to advance declarations of will.

This workshop is an opportunity for participants to influence the outcomes of Work Package 5 which focuses upon early diagnosis and intervention in dementia. We would like to invite you to participate in a discussion concerning the draft findings of the work that we have produced in this area.

In this workshop, you will initially receive a presentation which outlines the work we have carried out in:

  • Comparing national systems for the diagnosis of dementia in order to access to a common definition with associated operational criteria; and
  • Evaluating diagnostic systems in EU member states in order to formulate recommendations for improving early diagnosis, both in community and nursing home settings.

This presentation will be followed by a facilitated discussion concerning the recommendations made for improving early diagnosis across member states. The discussion and specifically your perspectives on the recommendations will inform the final report. We would very much appreciate your participation in this important opportunity to influence practice across Europe.



Last Updated: Wednesday 01 August 2012